VRPX
Vanguard Group’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-66,294
| Closed | -$21.2K | – | 4516 |
|
|
2023
Q4 | $21.2K | Buy |
66,294
+1,149
| +2% | +$368 | ﹤0.01% | 4444 |
|
|
2023
Q3 | $52.1K | Hold |
65,145
| – | – | ﹤0.01% | 4408 |
|
|
2023
Q2 | $70.4K | Hold |
65,145
| – | – | ﹤0.01% | 4421 |
|
|
2023
Q1 | $51.1K | Sell |
65,145
-112,591
| -63% | -$88.4K | ﹤0.01% | 4465 |
|
|
2022
Q4 | $111K | Sell |
177,736
-193,148
| -52% | -$120K | ﹤0.01% | 4378 |
|
|
2022
Q3 | $441K | Buy |
370,884
+28,907
| +8% | +$34.4K | ﹤0.01% | 4246 |
|
|
2022
Q2 | $575K | Hold |
341,977
| – | – | ﹤0.01% | 4256 |
|
|
2022
Q1 | $759K | Buy |
341,977
+14,672
| +4% | +$32.6K | ﹤0.01% | 4292 |
|
|
2021
Q4 | $1.12M | Buy |
327,305
+48,285
| +17% | +$166K | ﹤0.01% | 4238 |
|
|
2021
Q3 | $1.34M | Buy |
+279,020
| New | +$1.34M | ﹤0.01% | 4178 |
|